Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Investors

Latest TSX stock price

All prices delayed
at least 15 minutes.
Source: TSX Inc.

English French

Virtual Tour

Take a Virtual Tour of the Company's Vaccine Manufacturing Centre in Belleville, Ontario, Canada

Bioniche Life Sciences Inc.

Telesta Therapeutics Inc. (Formerly Bioniche Life Sciences Inc.) is focused on the development, manufacturing, and commercialization of proprietary and innovative therapeutics for the global human health market. The Company’s anchor product has completed Phase III clinical development to treat non-muscle-invasive bladder cancer and Telesta is seeking to file for marketing approval in the United States in Q1/2015.

The Company is publicly traded on the Toronto Stock Exchange and, effective on Monday, December 1st, its ticker will change to TSX:TST from TSX.BNC.

Website by: SNAP 360

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy



Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video
Close Window
Play Video